Genetic analysis of 31 Swedish type 1 von Willebrand disease families reveals incomplete linkage to the von Willebrand factor gene and a high frequency of a certain disease haplotype

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 12, 2005, Pages 2656-2663

  Lanke, E ^a   Johansson, A M ^b   Hallden C ^a   Lethagen, S ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

ABO; Coagulation; Genetic linkage; Microsatellite marker; Von Willebrand disease

Indexed keywords

CYSTEINE; TYROSINE; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP O; EXON; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; PRIORITY JOURNAL; VON WILLEBRAND DISEASE;

ABO BLOOD-GROUP SYSTEM; EPIDEMIOLOGY, MOLECULAR; FAMILY HEALTH; FEMALE; FOUNDER EFFECT; GENE FREQUENCY; HAPLOTYPES; HEMORRHAGE; HUMANS; LINKAGE (GENETICS); LOD SCORE; MALE; PEDIGREE; SWEDEN; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 29244478621     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01631.x     Document Type: Article

References (29)

1. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520-5.
2. Miller CH, Graham JB, Goldin LR, Elston RC. Genetics of classic von Willebrand's disease. I. Phenotypic variation within families. Blood 1979; 54: 117-36.
3. Mancuso DJ, Tuley EA, Westfield LA, Worrall NK, Shelton-Inloes BB, Sorace JM, Alevy YG, Sadler JE. Structure of the gene for human von Willebrand factor. J Biol Chem 1989; 264: 19514-27.
4. Mancuso DJ, Tuley EA, Westfield LA, Lester-Mancuso TL, Le Beau MM, Sorace JM, Sadler JE. Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction. Biochem 1991; 30: 253-69.
5. Rodeghiero F, Castaman G. Willebrand disease type I: definition, phenotypes, clinical and laboratory assessment. Best Pract Res Clin Haematol 2001; 14: 321-35.
6. Rodeghiero F. von Willebrand disease: still an intriguing disorder in the era of molecular medicine. Haemophilia 2002; 8: 292-300.
7. Mohlke KL, Nichols WC, Ginsburg D. The molecular basis of von Willebrand disease. Int J Clin Lab Res 1999; 29: 1-7.
8. Nitu-Whalley IC, Lee CA, Griffioen A, Jenkins PV, Pasi KJ. Type 1 von Willebrand disease - a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history. Br J Haemat 2000; 108: 259-64.
9. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
10. Kokame K, Matsumoto M, Soejima K, Yagi H, Ishizashi H, Funato M, Tamai H, Konno M, Kamide K, Kawano Y, Miyata T, Fujimura Y. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity. Proc Nat Acad Sci USA 2002; 99: 11902-7.
11. Bowen DJ. An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. J Thromb Haemost 2003; 1: 33-40.
12. Casaña P, Martínez F, Haya S, Espinós C, Aznar JA. Significant linkage and non-linkage of type 1 von Willebrand disease to the von Willebrand factor gene. Br J Haemat 2001; 115: 692-700.
13. Souto JC, Almasy L, Soria JM, Buil A, Stone W, Lathrop M, Blangero J, Fontcuberta J. Genome-wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project. Thromb Haemost 2003; 89: 468-74.
14. Zhang Z, Lindstedt M, Blombäck M, Anvret M. Effects of the mutant von Willebrand factor gene in von Willebrand disease. Hum Genet 1995; 96: 388-94.
15. Goodeve AC. Laboratory methods for the genetic diagnosis of bleeding disorders. Clin Lab Haem 1998; 20: 3-19.
16. O'Brien LA, James PD, Othman M, Berber E, Cameron C, Notley CRP, Hegadorn CA, Sutherland JJ, Hough C, Rivard GE, O'Shaunessey D, Lillicrap D. Willebrand factor haplotype associated with type l von Willebrand disease. Blood 2003; 102: 549-57.
17. Sadler JE, Rodeghiero F. Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost 2005; 3: 775-7.
18. Benson G. Tandem repeats finder: a program to analyze DNA sequences. Nucleic Acids Res 1999; 27: 573-80.
19. O'Connell JR, Weeks DE. A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63: 259-66.
20. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996; 58: 1347-63.
21. Castaman G, Eikenboom JCJ, Bertina RM, Rodeghiero F. Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation. Thromb Haemost 1999; 82: 1065-70.
22. Cumming AM, Armstrong JG, Pendry K, Burn AM, Wensley RT. Polymerase chain reaction amplification of two polymorphic simple repeat sequences within the von Willebrand factor gene: application to family studies in von Willebrand disease. Hum Genet 1992; 89: 194-8.
23. Inbal A, Kornbrot N, Zivelin A, Shaklai M, Seligsohn UT. The inheritance of type I and type III von Willebrand's disease in Israel: linkage analysis, carrier detection and prenatal diagnosis using three intragenic restriction fragment length polymorphisms. Blood Coagul Fibrinolysis 1992; 3: 167-77.
24. Anvret M, Blombäck M, Lindstedt M, Söderlind E, Tapper-Persson M, Thelander A-C. Genetic and blood coagulation characterization of "Swedish" families with von Willebrand's disease types I and III: new aspects of heredity. Hum Genet 1992; 89: 147-54.
25. Bowen DJ, Collins PW, Lester W, Cumming AM, Keeney S, Grundy P, Enayat SM, Bolton-Maggs PHB, Keeling DM, Khair K, Tait RC, Wilde JT, Pasi KJ, Hill FGH. The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: co-segregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype. Br J Haemat 2005; 128: 830-6.
26. Donnér M, Kristoffersson AC, Berntorp E, Scheibel E, Thorsen S, Dahlbäck B, Nilsson IM, Holmberg L. Two new candidate mutations in type IIA von Willebrand's disease (ARG834 → GLY, GLY846 → ARG) and one polymorphism (TYR821 → CYS) in the A2 region of the von Willebrand factor. Eur J Haematol 1993; 51: 38-44.
27. Bowen DJ, Collins PW. An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13. Blood 2004; 103: 941-7.
28. Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003; 101: 2089-93.
29. Sadler JE. Slippery criteria for von Willebrand disease type 1. J Thromb Haemost 2004; 2: 1720-3.